especially when you consider the long-term nature of these types of treatments
Wegovy is typically prescribed for people who are looking for an effective obesity treatment and is recommended for individuals with a body mass index (BMI) of 27 or higher and who have at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol, according to the drugs Health Canada approval statement
Related Reading Compounded Semaglutide 2 Compounded Semaglutide Medvi Semaglutide Bioverse Semaglutide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
In Brazil, the patent for the active ingredient in the drug Mounjaro , from Eli Lilly, expires in 2032
Foer D, Beeler PE, Cui J, Karlson EW, Bates DW, Cahill KN